GWMR
WST icon

GC Wealth Management RIA’s West Pharmaceutical WST Stock Holding History

GC Wealth Management RIA’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,170
Closed -$569K – 859
2025
Q3 		$569K Buy
+2,170
New +$527K 0.02% 515

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

GC Wealth Management RIA's WST Position: Q4 2025 in Review

GC Wealth Management RIA sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 2,170 shares — an estimated $569K sold.

GC Wealth Management RIA first reported a position in WST in Q3 2025 and held it in 1 quarter. The position peaked at $569K in Q3 2025. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • GC Wealth Management RIA reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • GC Wealth Management RIA sold 2,170 West Pharmaceutical shares in Q4 2025, an estimated $569K.
  • GC Wealth Management RIA first reported a position in West Pharmaceutical in Q3 2025 and held it in 1 quarter.
  • GC Wealth Management RIA's West Pharmaceutical position peaked at $569K in Q3 2025.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on GC Wealth Management RIA's 13F filing for Q4 2025, filed 30 Jan 2026.